Published in J Neurol Neurosurg Psychiatry on May 01, 2005
Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study. PLoS One (2013) 0.88
Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study. PLoS One (2013) 0.86
The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis. J Neurol (2008) 0.85
Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review. Neurol Sci (2015) 0.83
Subcutaneous Interferon Beta-1a Has a Positive Effect on Cognitive Performance in Mildly Disabled Patients with Relapsing-Remitting Multiple Sclerosis: 2-Year Results from the COGIMUS Study. Ther Adv Neurol Disord (2009) 0.77
Ocular motor signatures of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol (2015) 0.77
Processing speed versus working memory: contributions to an information-processing task in multiple sclerosis. Appl Neuropsychol Adult (2012) 0.76
Cognitive dysfunction in patients with multiple sclerosis treated with first-line disease-modifying therapy: a multi-center, controlled study using the BICAMS battery. Neurol Sci (2016) 0.75
Conceptual processing during the conscious resting state. A functional MRI study. J Cogn Neurosci (1999) 6.67
Genome sequence of the plant pathogen Ralstonia solanacearum. Nature (2002) 6.23
PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med (2001) 6.09
A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell (2001) 5.76
Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain (1999) 4.41
Human brain language areas identified by functional magnetic resonance imaging. J Neurosci (1997) 4.15
The epidemiology of nonfatal injuries among US children and youth. Am J Public Health (1995) 3.93
Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene (1993) 3.08
Maturation of neuroblastoma cells in the presence of dimethylsulfoxide. Proc Natl Acad Sci U S A (1976) 2.93
Determination of language dominance using functional MRI: a comparison with the Wada test. Neurology (1996) 2.71
Language processing is strongly left lateralized in both sexes. Evidence from functional MRI. Brain (1999) 2.71
Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest (2000) 2.67
Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. Am J Psychiatry (1998) 2.40
Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses. Neurology (1998) 2.39
A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res (1995) 2.23
In vitro induction of granulocyte differentiation in hematopoietic cells from leukemic and non-leukemic patients. Proc Natl Acad Sci U S A (1970) 2.22
Neuropsychology of multiple sclerosis: a critical review. J Clin Exp Neuropsychol (1986) 2.02
Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis. Arch Dermatol (1995) 1.88
Neural systems underlying the recognition of familiar and newly learned faces. J Neurosci (2000) 1.87
Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J (1996) 1.82
Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53 - MDM2 complexes. EMBO J (1993) 1.77
Can medial temporal lobe regions distinguish true from false? An event-related functional MRI study of veridical and illusory recognition memory. Proc Natl Acad Sci U S A (2001) 1.76
Functional magnetic resonance imaging of human auditory cortex. Ann Neurol (1994) 1.76
Multiple sclerosis-from probable to definite diagnosis: a 7-year prospective study. Arch Neurol (2000) 1.69
Neural mechanisms of visual attention: object-based selection of a region in space. J Cogn Neurosci (2000) 1.61
Sports and recreation injuries in US children and adolescents. Arch Pediatr Adolesc Med (1995) 1.54
Rotation of the anatomic regions used for insulin injections and day-to-day variability of plasma glucose in type I diabetic subjects. JAMA (1990) 1.50
Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology (1999) 1.49
Visual evoked potentials and visual acuity after transurethral resection of the prostate. Anaesthesia (1991) 1.49
Cross national study of injury and social determinants in adolescents. Inj Prev (2005) 1.49
Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study. Arch Gen Psychiatry (2001) 1.48
A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group. Int J Geriatr Psychiatry (2000) 1.47
Neural basis of endogenous and exogenous spatial orienting. A functional MRI study. J Cogn Neurosci (1999) 1.42
Congenital juvenile chronic myelogenous leukemia: therapeutic trial with interferon alpha-2. Med Pediatr Oncol (1993) 1.42
Lateralized human brain language systems demonstrated by task subtraction functional magnetic resonance imaging. Arch Neurol (1995) 1.41
Nose tapping test inducing a generalized flexor spasm: a hallmark of hyperexplexia. Acta Paediatr Scand (1991) 1.40
Hyperphosphatasemia in infantile GM1 gangliosidosis: possible association with microscopic bone marrow osteoblastosis. J Pediatr (1990) 1.40
The health of youth. A cross-national survey. WHO Reg Publ Eur Ser (1996) 1.38
Practice-related functional activation changes in a working memory task. Microsc Res Tech (2000) 1.38
Function of the left planum temporale in auditory and linguistic processing. Brain (1996) 1.37
Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry (2003) 1.28
Guidelines for neuropsychological research in multiple sclerosis. Arch Neurol (1990) 1.24
From preparation to online control: reappraisal of neural circuitry mediating internally generated and externally guided actions. Neuroimage (2006) 1.22
Semantic memory activation in amnestic mild cognitive impairment. Brain (2009) 1.18
Effect of chromate stress on Escherichia coli K-12. J Bacteriol (2006) 1.18
Memory disturbance in chronic progressive multiple sclerosis. Arch Neurol (1984) 1.13
Mapping of semantic, phonological, and orthographic verbal working memory in normal adults with functional magnetic resonance imaging. Neuropsychology (1999) 1.11
Mood disturbance versus other symptoms of depression in multiple sclerosis. J Int Neuropsychol Soc (1995) 1.11
The development, standardization, and initial validation of the Chicago Multiscale Depression Inventory. J Pers Assess (1998) 1.10
Validation of the Multiple Sclerosis International Quality of Life questionnaire. Mult Scler (2007) 1.10
Effects of stimulus rate on signal response during functional magnetic resonance imaging of auditory cortex. Brain Res Cogn Brain Res (1994) 1.09
Situational factors associated with AIDS risk behavior lapses and coping strategies used by gay men who successfully avoid lapses. Am J Public Health (1991) 1.07
Incidence and distribution of injury among schoolchildren aged 11-15. Inj Prev (1996) 1.07
Semantic memory activation in individuals at risk for developing Alzheimer disease. Neurology (2009) 1.04
Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood (2000) 1.03
Human growth hormone and insulin-like growth factor-1 enhance the proliferation of human leukemic blasts. J Clin Oncol (1991) 1.03
BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation. Br J Cancer (2008) 1.03
Specialized neural systems underlying representations of sequential movements. J Cogn Neurosci (2000) 1.01
Chediak-Higashi syndrome. Am J Pediatr Hematol Oncol (1987) 1.01
Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology (1994) 1.00
Ciprofloxacin inhibits human hematopoietic cell growth: synergism with tumor necrosis factor and interferon. Exp Hematol (1991) 0.99
Multiple sclerosis: specificity of MR for diagnosis. Radiology (1991) 0.99
Intracranial meningiomas: correlation of peritumoral edema and psychiatric disturbances. Psychiatry Res (1995) 0.99
hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21. Mol Psychiatry (1999) 0.99
Melatonin improves sleep quality of patients with chronic schizophrenia. J Clin Psychiatry (2000) 0.99
Functional magnetic resonance imaging of somatosensory stimulation. Neurosurgery (1994) 0.98
Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients. J Basic Clin Physiol Pharmacol (1995) 0.98
Sleep disturbances in children with attention-deficit/hyperactivity disorder: a comparative study with healthy siblings. J Learn Disabil (1998) 0.98
Latent viruses and Bell's palsy in children. Eur Neurol (1978) 0.97
Test characteristics of self-reported hypertension among the Hispanic population: findings from the Hispanic Health and Nutrition Examination Survey. J Clin Epidemiol (1990) 0.97
Influence of Volatile Fatty Acids on Nitrite Accumulation by a Pseudomonas stutzeri Strain Isolated from a Denitrifying Fluidized Bed Reactor. Appl Environ Microbiol (1996) 0.97
Late-onset multiple sclerosis. J Am Geriatr Soc (2001) 0.97
The epidemiology of non-fatal injuries among 11-, 13- and 15-year old youth in 11 countries: findings from the 1998 WHO-HBSC cross national survey. Int J Inj Contr Saf Promot (2006) 0.96
Dermoid cysts, hypothyroidism, cleft palate, and hypodontia. J Clin Dysmorphol (1983) 0.96
Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry (1995) 0.95
Stress and course of disease in multiple sclerosis. Behav Med (1999) 0.95
Oxidant stress and essential fatty acids in patients with risk and established ARDS. Clin Chim Acta (2000) 0.95
Bruxism: a critical review. Psychol Bull (1977) 0.94
Anomalous origin of the right coronary artery from the main pulmonary artery: diagnosis and management. Clin Cardiol (1998) 0.93
Executive functions in multiple sclerosis: an analysis of temporal ordering, semantic encoding, and planning abilities. Neuropsychology (1997) 0.92
The genetics of the aryl sulfatase A locus. Am J Hum Genet (1981) 0.92
Use of lasers in assisted fertilization and hatching. Hum Reprod (1994) 0.92
fMRI study of episodic memory in relapsing-remitting MS: correlation with T2 lesion volume. Neurology (2006) 0.92
Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients. Int Clin Psychopharmacol (2004) 0.91
Sleep disturbances, fibromyalgia and primary Sjögren's syndrome. Clin Exp Rheumatol (1997) 0.91
Fanconi anaemia group A (FANCA) mutations in Israeli non-Ashkenazi Jewish patients. Br J Haematol (2000) 0.90
Nasogastric tube as a tracheal tube introducer. Anaesthesia (1995) 0.90
In vitro induction of myeloid proliferation and maturation in infantile genetic agranulocytosis. Blood (1971) 0.89
A new approach to affective symptoms in relapsing-remitting multiple sclerosis. Compr Psychiatry (1996) 0.89
Metachromatic leukodystrophy in the habbanite Jews: high frequency in a genetic isolate and screening for heterozygotes. Am J Hum Genet (1980) 0.89
Pyoderma gangrenosum and sterile multifocal osteomyelitis preceding the appearance of Takayasu arteritis. Pediatr Dermatol (1995) 0.88
T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patients. Clin Immunol (2004) 0.88
Response of neonatal hypocalcaemia to 1 alpha-hydroxyvitamin D3. Arch Dis Child (1979) 0.87
Cognitive changes in early MS: a call for a common framework. J Neurol Sci (2006) 0.87
Abnormal liver test results in myotonic dystrophy. J Clin Gastroenterol (1998) 0.86
Prolonged response times characterize cognitive performance in multiple sclerosis. Eur J Neurol (2007) 0.86
Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience. Surgery (2007) 0.85
Cryptogenic liver disease in HIV-seropositive men. HIV Med (2009) 0.85